Outline

JEIM

Multi-Omics and Network-Based Prioritization of Immune Dysfunction Genes Using Integrated Genomic and Transcriptomic Data

Author(s): Alexander A. Morgan1, Rong Chen2, Atul Janardhan Butte2,3
1Stanford Genome Technology Center, Stanford University, USA.
2Division of Systems Medicine, Department of Pediatrics, Stanford University, USA.
3Lucile Packard Children’s Hospital, Palo Alto, California, USA.
[mla_citation]

Abstract

Identification of disease-associated genes remains a major challenge in the study of primary
immunodeficiency disorders. Traditional genomic studies often rely on either genetic
association data or transcriptomic evidence alone. However, complex immune disorders
involve interactions among multiple genes, regulatory pathways, and environmental factors.
In this study we propose a multi-omics gene prioritization framework that integrates transcriptomic meta-analysis, genomic variant data, and protein interaction networks to identify candidate immune dysfunction genes. By combining heterogeneous biological datasets
and network-based ranking methods, the proposed approach improves the prioritization of
genes associated with immune disorders. Results demonstrate that integrating multi-omics
data significantly enhances the identification of biologically relevant genes compared with
single-data-type approaches. This framework provides a powerful strategy for studying
complex immune diseases and supports the development of precision medicine approaches
for immunodeficiency disorders.

Keywords
Multi-omics integration; Immunodeficiency; Gene prioritization; Network analysis; Precision medicine.

Related Articles

Azra Nishat1, Shazadi Sultana2, Arshiya Sultana2
1Department of Obstetrics and Gynecology, Government Nizamia Tibbi College Charminar, Hyderabad, India
2Department of Obstetrics and Gynecology, National Institute of Unani Medicine, PG Institute of Research, Bengaluru, Karnataka, India.
Rinaldo Bellomo1,2, John A. Kellum3, Claudio Ronco4
1Department of Intensive Care, Austin Hospital, Melbourne, Australia
2School of Medicine, The University of Melbourne, Australia
3Center for Critical Care Nephrology, University of Pittsburgh, USA.
4International Renal Research Institute, Vicenza, Italy.
Ivica Letunic1, Lars Nielsen1, Peer Bork2,3
1Biobyte solutions GmbH, Bothestr 142, 69126 Heidelberg, German
2EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
3Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany.
Michael Henderson1, Carol Inatsuka2, Amanda J. Sheets1, Corinne L. Williams3, David J. Benaron2, Gina M. Donato4, Mary C. Gray4, Erik L. Hewlett4, Peggy A. Cotter1,3
1Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, USA.
2Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA.
3Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA
4Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, USA
Eisha Nisar1, Rong Chen2, Atul Janardhan Butte2
1Faisalabad Medical University, faisalabad, Pakistan.
2Lucile Packard Children’s Hospital, Palo Alto, California, USA.
Olusola Ayanniyi1, Olusoji G. Ige2
1Department of Physiotherapy, College of Medicine, University of Ibadan, Ibadan, Nigeria.
2Physiotherapy Department, College of Medicine, University of Ibadan/UCH, Ibadan, Nigeria.